Access to up to date information has never been easier. Smart devices and the internet provide individuals across all economic spectrums with rapid access to information. Interestingly, this ease of availability has led to a deluge of misinformation. This problem is evident in politics, news, and health care. One such example is the anti-vax movement, which seeks to undermine trust in vaccination. Recent outbreaks of measles in eastern Europe and the recurrence of polio in Nigeria can be directly associated with anti-vaccination misinformation. Further dissemination and mistrust of medical information seeks to exacerbate the Ebola crisis occurring in the Democratic Republic of the Congo. *EClinicalMedicine* launched a year ago this month, with the aim of aiding researchers in accurately communicating research, which impacts a variety of aspects of health care, and simultaneously building on the reputation of peer review excellence, transparency, and reproducibility set forward for us by our sister journals at *The Lancet*. Advancing on the ideals of *The Lancet,* we developed a mission statement of our own. We intend to publish studies containing outcomes and data with the courage and vision to rethink and reframe the future of health and health care. With this commitment, we intend *EClinicalMedicine* to be a home for exciting and rigorous research. In celebration of this anniversary, we are highlighting a selection of the studies that represent our commitment to assisting practitioners and health-care professionals cut through the glut of misinformation.

Studies that show the utility of new clinical tools are important. The large number of clinical tools in some disciplines can cause confusion for practitioners as to which are the most appropriate to use. The open access nature of *EClinicalMedicine* means such studies are immediately available to clinicians and practitioners in both the global north and south. The Articles; Congo Red Dot Paper Test for Antenatal Triage and Rapid Identification of Preeclampsia and Development and Validation of an Immunoassay for Tenofovir in Urine as a Real-Time Metric of Antiretroviral Adherence are important examples for clinical diagnostics. Kara Rood and colleagues evaluated the clinical utility of The Congo Red Dot Paper test---an easy to use, non-invasive, low-cost, paper-based, point-of-care test to diagnose preeclampsia (<https://doi.org/10.1016/j.eclinm.2019.02.004>). Their study provided data on the test's utility in a clinical setting, creating an evidence base for the tests use as standard. Similarly, Monica Gandhi and colleagues developed a simple urine test to monitor Tenofovir adherence, which is used as part of HIV pre-exposure prophylaxis (PrEP; <https://doi.org/10.1016/j.eclinm.2018.08.004>). This test fills the need for a reliable adherence metric as part of future PrEP roll-out programmes. Both tests will have particular utility in the global south where preeclampsia and HIV are serious health-care challenges.

Studies that seek to resolve safety concerns in treatment modalities are similarly essential. Accurate reporting and well described studies can help to provide confidence in treatment modalities. In Immediate Hypersensitivity to Contrast Agents: The French 5-year CIRTACI Study, the frequency of immediate hypersensitivity to iodinated or gadolinium-based media was assessed (<https://doi.org/10.1016/j.eclinm.2018.07.002>). The study provided important data on differences in contrast agent sensitivity, prompting guidance on skin testing before use of contrast media in patients. Jackie Swartz and colleagues assessed associations between early childhood vaccination and allergic reactions in their study Vaccination and Allergic Sensitization in Early Childhood---The ALADDIN Birth Cohort (<https://doi.org/10.1016/j.eclinm.2018.10.005>). In the current climate of easily disseminated anti-vaccination rhetoric, studies such as these provide confidence for both clinicians and the public.

Finally, the use of automated diagnostic technology in clinical practice is growing at an incredible pace. Artificial intelligence (AI) and health-care interactions are on the rise. Accurately communicating both the potential and limitations of AI are important to encourage its use and proper implementation. The study by Haotian Lin and colleagues, Diagnostic Efficacy and Therapeutic Decision-making Capacity of an Artificial Intelligence Platform for Childhood Cataracts in Eye Clinics: A Multicentre Randomized Controlled Trial shows the potential of these interactions (<https://doi.org/10.1016/j.eclinm.2019.03.001>). The investigators presented one of the first randomised control trials comparing the diagnostic accuracy and efficiency of medical AI with senior consultants in diagnosing childhood cataracts. This study revealed differences in accuracy and speed between the algorithm and trained clinicians, showing the real-world potential of such technology.

Accurate dissemination of medical research has never been more important. With more avenues for individuals to obtain research data and more research being done, it is imperative that published work is accurately communicated. In practise, this means we must ensure rigorous peer review of studies and accurate interpretation and reporting of the results. In this first year we have helped researchers publish studies with true impact, elucidating clinical concerns essential to practitioners and primary caregivers. As the relationships between medicine and information technology change, we intend to continue to grow to meet the challenges.
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